Insider sale
DYNE THERAPEUTICS, INC.
$54.5K
3.14K shares
What this filing means
ATLAS VENTURE OPPORTUNITY FUND II, L.P. plans to sell 3.14K shares of DYNE THERAPEUTICS, INC. valued at approximately $54.5K. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 5/4/2026ACC: 0001628280-26-029908
10% Owner
Since Dec 2022
3.14K
Shares to sell
$54.5K
Approx. market value
3.14K
Acquired (3 months)
1
Planned
Securities Acquired — Last 3 Months1
Private Placement
Cash
12/12/2022
3.14KTotal acquired3.14K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
12/12/2022 | Private Placement Cash | 3.14K | — |
| Total | 3.14K | ||
Planned & Completed Dispositions1
NasdaqPlanned
Units to sell
3.14K
Market value
$54.5K
5/4/2026
Total
Units
3.14K
Value
$54.5K
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
5/4/2026 | 3.14K | $54.5K | Nasdaq | Planned |
| Total | 3.14K | $54.5K | ||